Here & Now Here & Now

Support the news

Cholesterol Drug Vytorin Found To Lower Heart Risk06:05
Download

Play
This article is more than 5 years old.

Heart disease is the leading cause of death in the United States. Statins have long been the drug of of choice to lower cholesterol to reduce the rise of heart attacks and strokes.

But a new study — funded by Merck — finds that the drug Vytorin, which combines the statin Zocor with the drug Zetia, is more effective than statins alone at lowering cholesterol and reducing the risk of cardiovascular disease in patients who have had a heart attack or severe chest pain.

Dr. Lori Mosca, director of preventative cardiology at New York Presbyterian Hospital, tells Here & Now's Robin Young about her experience treating patients with Vytorin and how the drug works.

Guest

This segment aired on November 18, 2014.

Support the news

Support the news